作者: Jaime Feliu Batlle , Enrique Espinosa Arranz , Javier de Castro Carpeño , Enrique Casado Sáez , Pilar Zamora Auñón
DOI:
关键词:
摘要: Although oral chemotherapeutic agents have been available for the last 50 years, some reservations about their efficacy and the limited interest of pharmaceutical companies have hampered their widespread use. This situation will probably change in the near future as several new oral anticancer agents have been approved and there are more in development. Convenience and easiness of administration make of oral chemotherapy an attractive option. It avoids the complications and costs derived from intravenous chemotherapy, while maintaining the patients' quality of life. It also allows the replacement of drugs that require protracted administration periods. On the other hand, variable bioavailability and non-compliance appear as the main problems: the former depends on the pharmacological characteristics of the compound, whereas the latter involves time to train the patients and their families …